Medprin Regenerative Medical Technologies Co. Ltd.
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a S… Read more
Market Cap & Net Worth: Medprin Regenerative Medical Technologies Co. Ltd. (301033)
Medprin Regenerative Medical Technologies Co. Ltd. (SHE:301033) has a market capitalization of $593.80 Million (CN¥4.36 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #12879 globally and #3260 in its home market, demonstrating a -5.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medprin Regenerative Medical Technologies Co. Ltd.'s stock price CN¥64.98 by its total outstanding shares 67049620 (67.05 Million).
Medprin Regenerative Medical Technologies Co. Ltd. Market Cap History: 2021 to 2026
Medprin Regenerative Medical Technologies Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $548.84 Million to $593.80 Million (-1.53% CAGR).
Medprin Regenerative Medical Technologies Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medprin Regenerative Medical Technologies Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.38x
Medprin Regenerative Medical Technologies Co. Ltd.'s market cap is 1.38 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
4.87x
Medprin Regenerative Medical Technologies Co. Ltd.'s market cap is 4.87 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $548.84 Million | $153.79 Million | $44.71 Million | 3.57x | 12.27x |
| 2022 | $332.12 Million | $195.25 Million | $35.89 Million | 1.70x | 9.25x |
| 2023 | $393.78 Million | $230.87 Million | $40.88 Million | 1.71x | 9.63x |
| 2024 | $384.26 Million | $278.44 Million | $78.85 Million | 1.38x | 4.87x |
Competitor Companies of 301033 by Market Capitalization
Companies near Medprin Regenerative Medical Technologies Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Medprin Regenerative Medical Technologies Co. Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Medprin Regenerative Medical Technologies Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Medprin Regenerative Medical Technologies Co. Ltd.'s market cap moved from $548.84 Million to $ 593.80 Million, with a yearly change of -1.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥593.80 Million | -3.73% |
| 2025 | CN¥616.83 Million | +60.52% |
| 2024 | CN¥384.26 Million | -2.42% |
| 2023 | CN¥393.78 Million | +18.56% |
| 2022 | CN¥332.12 Million | -39.49% |
| 2021 | CN¥548.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Medprin Regenerative Medical Technologies Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $593.80 Million USD |
| MoneyControl | $593.80 Million USD |
| MarketWatch | $593.80 Million USD |
| marketcap.company | $593.80 Million USD |
| Reuters | $593.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.